Filing Details
- Accession Number:
- 0001022079-20-000059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-28 17:50:43
- Reporting Period:
- 2020-02-26
- Accepted Time:
- 2020-02-28 17:50:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1599837 | E. J. Davis | 500 Plaza Drive Secaucus NJ 07094 | Evp, General Diagnostics | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-02-26 | 510 | $111.09 | 40,392 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-02-26 | 1,187 | $112.90 | 39,205 | No | 4 | F | Direct | |
Common Stock | Disposition | 2020-02-27 | 1,100 | $109.02 | 38,105 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019.
- Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units.